Abiopharma

News list

(75% Positive) MAZE THERAPEUTICS, INC. (MAZE) Provides Update on initiations for both molecules next year

Full text

News bot Aug. 17, 2026, 8:18 p.m.
📋 MAZE THERAPEUTICS, INC. (MAZE) - Clinical Trial Update

Filing Date: 2026-08-17

Accepted: 2026-08-17 16:16:30

Event Type: Clinical Trial Update
Event Details:
MAZE THERAPEUTICS, INC. (MAZE) Announces Clinical Trial Update MAZE THERAPEUTICS, INC. (MAZE) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: initiations, time
Diseases/Conditions: both molecules next year, our company
Collaboration: Board
💼 Business Developments:
- Partnership: Not available
- Acquisition
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: MAZE THERAPEUTICS, INC.
- Ticker Symbol: MAZE